LeMaitre brings remote endarterectomy to the fore with $2.8m buy
This article was originally published in Clinica
Vascular implants and devices manufacturer Lemaitre Vascular has brought remote endarterectomy (RE) technology to its product portfolio after purchasing Vascular Architects in an all-cash deal worth $2.8m. The purchase price represents a 1.6 multiple of Vascular's revenues of $1.8m over the last twelve months.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.